Bergers E, van Diest P J, Baak J P
Department of Pathology, Free University Hospital, Amsterdam, The Netherlands.
Cytometry. 1997 Feb 15;30(1):54-60.
Conflicting prognostic results with regard to DNA flow cytometric variables have been reported for breast cancer patients. Reasons for this can be found mainly on the different levels of methodology, including the interpretation of the DNA-histograms. Several computer programs based on different fitting models are available for cell cycle analyses which result in different %S-phase calculations. The present study evaluated the influence of 5 different cell cycle analysis models on several cell cycle variables (%S-phase, %G2M-phase, %diploid cells, DNA-index, %debris) derived from flow cytometric DNA-histograms obtained from breast cancers. DNA-histograms obtained from 1414 fresh frozen breast cancers were interpreted using 5 different cell cycle analysis models using the computer program MultiCycle AV. Model 1 used the zero order S-phase calculation and "sliced nuclei" debris correction, model 2 added fixed G0/G1 and G2/M-phase ratio, and model 3 added correction for aggregates. Model 4 applied the first order S-phase calculation and sliced nuclei debris correction. Model 5 fixed the CVs of the G0/G1 and G2/M-phase in addition to applying the sliced nuclei debris correction and zero-order S-phase calculation. Using all cases, it was shown that when the aggregates correction was included (model 3) in the analysis, on average, significantly lower mean values were obtained for %S-phase cells, and %debris, and %G2M-phase cells of the first cell cycle. No significant differences were observed for the other variables. Analyzing the DNA-diploid, tetraploid, and aneuploid cases separately, similar results were obtained. Linear regression analysis showed only moderately strong correlations for the %S-phase and %G2M-phase variables between the different models, indicating that for individual DNA-histograms the cell cycle analysis results may vary. In conclusion, quite different values can be obtained for especially the %S-phase cells using different cell cycle analysis models in individual cases. Correction for aggregates results on average in significantly lower %S-phase values. This clearly has implications for comparing %S-phase results from studies using aggregate correction or not, especially with regard to prognostic thresholds. Large follow-up studies are necessary to derive at the prognostically best model.
关于乳腺癌患者,已有报道称DNA流式细胞术变量的预后结果相互矛盾。造成这种情况的原因主要可以在不同的方法学层面找到,包括DNA直方图的解读。有几种基于不同拟合模型的计算机程序可用于细胞周期分析,这导致了不同的S期百分比计算结果。本研究评估了5种不同细胞周期分析模型对从乳腺癌流式细胞术DNA直方图得出的几个细胞周期变量(S期百分比、G2M期百分比、二倍体细胞百分比、DNA指数、碎片百分比)的影响。使用计算机程序MultiCycle AV,采用5种不同细胞周期分析模型对从1414例新鲜冷冻乳腺癌中获得的DNA直方图进行解读。模型1使用零阶S期计算和“切片细胞核”碎片校正,模型2增加了固定的G0/G1和G2/M期比例,模型3增加了聚集体校正。模型4应用一阶S期计算和切片细胞核碎片校正。模型5除了应用切片细胞核碎片校正和零阶S期计算外,还固定了G0/G1和G2/M期的变异系数。使用所有病例的数据表明,当分析中纳入聚集体校正(模型3)时,第一个细胞周期的S期细胞百分比、碎片百分比和G2M期细胞百分比的平均值平均显著降低。其他变量未观察到显著差异。分别分析DNA二倍体、四倍体和非整倍体病例,得到了类似的结果。线性回归分析显示,不同模型之间S期百分比和G2M期百分比变量的相关性仅为中等强度,这表明对于单个DNA直方图,细胞周期分析结果可能会有所不同。总之,在个别情况下,使用不同的细胞周期分析模型,尤其是对于S期细胞百分比,可以得到截然不同的值。聚集体校正平均导致S期百分比值显著降低。这显然对比较使用或不使用聚集体校正的研究中的S期百分比结果有影响,特别是在预后阈值方面。需要进行大型随访研究以得出预后最佳的模型。